Henoch-Schonlein purpura nephritis

Clinical trials for Henoch-Schonlein purpura nephritis explained in plain language.

Never miss a new study

Get alerted when new Henoch-Schonlein purpura nephritis trials appear

Sign up with your email to follow new studies for Henoch-Schonlein purpura nephritis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kids with kidney disease: drug trial targets protein leak

Disease control Recruiting now

This study tests a drug called ravulizumab in children aged 2 to 18 with a kidney disease called IgA nephropathy. The goal is to see if the drug can reduce protein in the urine, a sign of kidney damage. Participants will receive the drug through an IV and be monitored for safety …

Matched conditions: HENOCH-SCHONLEIN PURPURA NEPHRITIS

Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

Henoch-Schonlein purpura nephritis

Get alerted when new Henoch-Schonlein purpura nephritis trials appear

New hope for kids with kidney disease: drug trial targets protein leak